Open original FDA record ↗Recall record
- FDA identifier
- Z-0673-03
- Company in FDA record
- Cryolife Inc
- FDA classification date
- Mar 21, 2003
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Microorganisms were detected in distributed donor tissue.
Source facts
- Action
- Medical facilities were contacted by CryoLife Technical Representatives via letter on/about 2/20/2003 to alert the facility of the removal and to determine the disposition of the allografts. Firms were advised, if the tissue has not been implanted, not to implant or distribute the tissue and to place it into quarantine. Consignees were to contact CryoLife''s Regulatory Affairs Department-Field Assurance, and a representative would issue a Return Materials Authorization number and will provide specific instructions for returning the tissue. There is a stamped, self addressed postcard attached to affirm receipt of the notification.
- Initiated
- 2003-02-18
- Root cause
- Other
- Terminated
- 2003-07-21
- Distribution
- Tissue products were distributed to Medical facilities located in CA, MD, ME and SD. There were no foreign or government accounts.
- Recall number
- Z-0673-03
- Recall status
- Terminated
- CDRH record ID
- 26186
- FDA classified
- 2003-03-21
- Recall event number
- 25635